Novartis Provides Update on AVXS-101 Intrathecal Clinical Development Program
Sep 23, 2020
- Novartis Gene Therapies to initiate new pivotal confirmatory study to evaluate use of AVXS-101?intrathecal (IT) formulation?in older patients with SMA to further support registration